T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dollar General
DG
|
+$1.37B |
| 2 |
Intel
INTC
|
+$1.28B |
| 3 |
SCHW
Charles Schwab
SCHW
|
+$1B |
| 4 |
Nike
NKE
|
+$859M |
| 5 |
Uber
UBER
|
+$825M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$2.67B |
| 2 |
Amazon
AMZN
|
+$2.15B |
| 3 |
NVIDIA
NVDA
|
+$1.64B |
| 4 |
Humana
HUM
|
+$1.57B |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$1.33B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.09% |
| 2 | Healthcare | 15.81% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Communication Services | 8.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
801
Delta Air Lines
DAL
$60B
| $34.8M | ﹤0.01% |
864,039
-482,111
| -36% | -$17.5M |
|
802
Haemonetics
HAE
$4.11B
| $34.7M | ﹤0.01% |
405,789
-114,335
| -22% | -$9.88M |
|
|
INFA
803
DELISTED
Informatica
INFA
| $34.5M | ﹤0.01% |
1,216,303
+28,453
| +2% | +$684K |
|
804
Mirum Pharmaceuticals
MIRM
$6.02B
| $34.4M | ﹤0.01% |
1,164,682
+1,132,723
| +3,544% | +$34.3M |
|
805
Natera
NTRA
$44.8B
| $34.3M | ﹤0.01% |
548,152
-82,261
| -13% | -$4.11M |
|
|
JBTM
806
JBT Marel
JBTM
$6.1B
| $34.3M | ﹤0.01% |
344,717
-26,243
| -7% | -$2.72M |
|
807
Disc Medicine
IRON
$3.07B
| $34.1M | ﹤0.01% |
590,831
+63,092
| +12% | +$3.23M |
|
|
DAWN
808
DELISTED
Day One Biopharmaceuticals
DAWN
| $33.8M | ﹤0.01% |
2,316,764
+8,736
| +0.4% | +$106K |
|
809
Warner Bros
WBD
$69.6B
| $33.8M | ﹤0.01% |
2,967,297
+73,912
| +3% | +$798K |
|
810
Iron Mountain
IRM
$37.7B
| $33.7M | ﹤0.01% |
482,222
+7,779
| +2% | +$488K |
|
811
NovoCure
NVCR
$2.02B
| $33.6M | ﹤0.01% |
2,253,225
-111,234
| -5% | -$1.49M |
|
812
Arcos Dorados Holdings
ARCO
$1.71B
| $33.6M | ﹤0.01% |
2,650,801
+613,922
| +30% | +$6.57M |
|
|
AZEK
813
DELISTED
The AZEK Co
AZEK
| $33.6M | ﹤0.01% |
879,038
+820,264
| +1,396% | +$25.6M |
|
814
Grupo Aeroportuario del Sureste
ASR
$8.01B
| $33.6M | ﹤0.01% |
114,156
+20,836
| +22% | +$4.92M |
|
815
Constellium
CSTM
$3.95B
| $33.5M | ﹤0.01% |
1,677,331
+3,232
| +0.2% | +$56.6K |
|
816
StoneX
SNEX
$8.05B
| $33.2M | ﹤0.01% |
1,516,259
-3,347
| -0.2% | -$63.6K |
|
817
Pultegroup
PHM
$24.9B
| $33M | ﹤0.01% |
319,389
-3,434
| -1% | -$292K |
|
818
McGrath RentCorp
MGRC
$2.94B
| $33M | ﹤0.01% |
275,493
-34,823
| -11% | -$3.62M |
|
819
First Industrial Realty Trust
FR
$8.4B
| $32.8M | ﹤0.01% |
623,334
+15,600
| +3% | +$727K |
|
820
Rentokil
RTO
$12.1B
| $32.8M | ﹤0.01% |
1,147,353
-112,804
| -9% | -$3.31M |
|
821
LyondellBasell Industries
LYB
$20.2B
| $32.8M | ﹤0.01% |
345,109
+5,196
| +2% | +$486K |
|
822
Entergy
ETR
$49.9B
| $32.7M | ﹤0.01% |
647,164
-18,846
| -3% | -$920K |
|
823
Blackbaud
BLKB
$2.1B
| $32.7M | ﹤0.01% |
377,454
+14,616
| +4% | +$1.11M |
|
824
CONMED
CNMD
$1.49B
| $32.7M | ﹤0.01% |
298,338
-2,899
| -1% | -$300K |
|
825
Simply Good Foods
SMPL
$989M
| $32.5M | ﹤0.01% |
821,335
-6,301
| -0.8% | -$235K |
|
Similar funds
T. Rowe Price Associates's Q4 2023 Portfolio in Review
As of Q4 2023, T. Rowe Price Associates held 2,974 positions worth $744B, up 9.1% from $682B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
T. Rowe Price Associates's Q4 2023 filing shows 92 new, 1,834 increased, 805 reduced and 67 closed positions. Its largest new stake was Canadian Natural Resources: 6,473,658 shares worth $212M. The largest sale was Microsoft, an estimated $2.67B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 30% a quarter earlier, followed by Healthcare and Financials.
- T. Rowe Price Associates's largest Q4 2023 buy was Canadian Natural Resources: 6,473,658 shares worth $212M.
- T. Rowe Price Associates added most to Dollar General in Q4 2023, an estimated $1.37B increase.
- T. Rowe Price Associates's biggest Q4 2023 reduction was Microsoft, cutting an estimated $2.67B.
- T. Rowe Price Associates fully exited Activision Blizzard in Q4 2023, selling an estimated $293M.
- T. Rowe Price Associates's ten largest holdings make up 31% of its $744B portfolio in Q4 2023.
- T. Rowe Price Associates opened 92 new positions and closed 67 in Q4 2023.
- T. Rowe Price Associates's portfolio value rose 9.1% quarter-over-quarter to $744B.
Based on T. Rowe Price Associates's 13F filing for Q4 2023, filed 14 Feb 2024.